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Invasive fungal infections have a high rate of morbidity andmortality, and accurate identification is necessary to guide appropri-
ate antifungal therapy. With the increasing incidence of invasive disease attributed to filamentous fungi, rapid and accurate spe-
cies-level identification of these pathogens is necessary. Traditional methods for identification of filamentous fungi can be slow
andmay lack resolution. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOFMS) has
emerged as a rapid and accurate method for identification of bacteria and yeasts, but a paucity of data exists on the performance
characteristics of this method for identification of filamentous fungi. The objective of our study was to evaluate the accuracy of
the VitekMS for mold identification. A total of 319 mold isolates representing 43 genera recovered from clinical specimens were
evaluated. Of these isolates, 213 (66.8%) were correctly identified using the VitekMS Knowledge Base, version 3.0 database.
When amodified SARAMIS (Spectral Archive andMicrobial Identification System) database was used to augment the version
3.0 Knowledge Base, 245 (76.8%) isolates were correctly identified. Unidentified isolates were subcultured for repeat testing; 71/
319 (22.3%) remained unidentified. Of the unidentified isolates, 69 were not in the database. Only 3 (0.9%) isolates were mis-
identified by MALDI-TOFMS (including Aspergillus amoenus [n 2] and Aspergillus calidoustus [n 1]) although 10 (3.1%) of
the original phenotypic identifications were not correct. In addition, this methodology was able to accurately identify 133/144
(93.6%) Aspergillus sp. isolates to the species level. MALDI-TOFMS has the potential to expedite mold identification, andmis-
identifications are rare.
Filamentous fungi are ubiquitous environmental microorgan-isms that have become increasingly important pathogens, es-
pecially in immunocompromised patients. Invasive fungal dis-
eases have a high rate of morbidity and mortality, and accurate
identification is necessary to guide appropriate antifungal ther-
apy. Traditionally, the identification of filamentous fungi has re-
quired the use of different phenotypic methods in conjunction
with macro- and microscopic assessment of the organism (1).
This process requires highly trained mycologists, and, in some
cases, turnaround time may be prolonged due to a requirement
for extended incubation periods, potentially delaying appropriate
therapy. Molecular methods, which can provide accurate identi-
fication to the species level, can be expensive, require specialized
equipment or expertise, and are not commonly available in clini-
cal laboratories.
Matrix-assisted laser desorption ionization–time of flightmass
spectrometry (MALDI-TOF MS) has been utilized in the clinical
microbiology laboratory for rapid and accurate identification of
bacteria, mycobacteria, and yeasts (2–9). For filamentous fungi,
databases have been limited, and unlike bacteria, filamentous
fungi require additional processing steps to disrupt the cell wall,
extract proteins, and inactivate the isolate (10). These additional
processing steps and limited libraries have led laboratories to de-
velop their own methodologies and databases to overcome these
barriers to adoption (11–13). These limitations have hindered
widespread implementation of this technology in the clinical lab-
oratory for the identification of filamentous fungi.
Here, our objective was to evaluate the identification of fila-
mentous fungi by the Vitek MS system with the Knowledge Base
version 3.0 database and SpectraIdentifier R2.1.0 software that is
currently in development. This updated library contains 82
unique species from 31 different genera of filamentous fungi.
(This work was presented in part as a poster at the 114th Gen-
eral Meeting of the American Society for Microbiology, Boston,
MA, 17 to 20 May 2014 [14]).
MATERIALS AND METHODS
Clinical isolates. A total of 319 isolates of filamentous fungi representing
43 genera recovered from clinical samples submitted to the Barnes Jewish
Hospital microbiology laboratory were analyzed; these isolates were re-
covered between 2008 and 2014. Isolates were identified using standard-
of-care phenotypic characterization in the Barnes Jewish Hospital clinical
microbiology laboratory. For MALDI-TOF MS analysis, all isolates were
cultivated on Sabouraud dextrose agar (Remel, Lenexa, KS). Rapidly
growing species were tested after 2 to 3 days of incubation, and slowly
growing species were tested after 7 to 10 days of incubation at room
temperature.
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Mold inactivation and extraction. Isolates were processed according
to the inactivation/extraction protocol for molds and Vitek MS identifi-
cation (bioMérieux, Hazelwood, MO). In brief, hyphae and/or conidia
were collectedwith amoistened sterile cotton swab (PuritanMedial Prod-
ucts, Guilford, ME) from a 1- to 2-cm diameter of growth and inoculated
into 900 l of 70% ethanol (Sigma-Aldrich, St. Louis, MO) in a micro-
centrifuge tube. The suspension was vortexed for 3 to 5 s and centrifuged
at 10,000 g for 2min. The supernatant was discarded, and the pellet was
resuspended with 40 l of 70% formic acid (Sigma-Aldrich), followed by
the addition of 40l of acetonitrile (Sigma-Aldrich). The suspension was
vortexed for 3 to 5 s and centrifuged again at 10,000  g for 2 min. One
microliter of supernatant was transferred to the target slide. Once the
sample was dry, 1 l of matrix (-cyano-4-hydroxy-cinnamic acid; bio-
Mérieux) was applied and allowed to dry prior to analysis. For each iso-
late, a single extraction was performed and spotted in duplicate. An Esch-
erichia coli reference strain (ATCC8739)was directly spotted and overlaid
with matrix on each acquisition group on each slide as a calibrant and
quality control per the manufacturer’s protocols.
MALDI-TOF MS analysis. Isolates were tested using the Vitek MS
system. Spectra obtained from the Vitek MS were analyzed using the
Knowledge Base, version 3.0 database and SpectraIdentifier R2.1.0 soft-
ware. For data analysis, any Vitek MS identification and score reported
were acceptable. If no identification was obtained, the isolate was re-
peated. Repeat testing consisted of resubbing the isolate, incubating it for
the desired length of time, and repeating the inactivation and extraction
procedure. If an isolate did not yield identification upon repeat testing, it
was labeled as “no identification.”
Evaluating spectra. Isolates that remained unidentified upon repeat
of the MALDI-TOF MS analysis were further analyzed using the SARA-
MIS (Spectral Archive andMicrobial Identification System) database. Iso-
lates that were related to isolates previously identified or that had been
sent for sequencing were compared to spectra in the database. Isolate
spectra were grouped together in a taxonomy tree using the SARAMIS,
version 4.12, software/analysis tool. Isolates that clustered with a relative
taxonomy of approximately65% were considered related at the species
level. Outliers were removed from the taxonomy tree, and a superspec-
trum was created with the remaining isolate spectra. Superspectra added
to the database were used for future isolate identification.
Sequencing. Isolates that had discrepant phenotypic identification
compared to theMALDI-TOFMS identification and unidentified isolates
were sent to the Fungus Testing Laboratory at the University of Texas
Health Science Center (San Antonio, TX). Gene targets for sequencing
were chosen based on the presumptive species identification by morpho-
logical characteristics. For the majority of the isolates, the internal tran-
scribed spacer region 1/2 (ITS1/2) was sequenced; this was augmented
with D1/D2 (domain of 26S), beta-tubulin (TUB), elongation factor
(TEF), actin (ACT), or glyceraldehyde-3-phosphate dehydrogenase
(GPD), as appropriate for the taxa being evaluated.
RESULTS
Correct identifications by Vitek MS. A total of 319 isolates of
filamentous fungi representing 43 genera were evaluated in this
study. Out of those isolates, 213 (66.8%) were correctly identified
using the Vitek MS Knowledge Base version 3.0 database and
SpectraIdentifier R2.1.0 software (Table 1). An additional 32 iso-
lates were identified after analyses with our modified SARAMIS
database, for a total of 245 (76.8%) correct identifications. Eighty-
six percent (125/144) of Aspergillus species isolates were initially
identified, and eight more were correctly identified upon further
analyses with the SARAMIS software; 98.9% of Aspergillus flavus
and Aspergillus fumigatus, two common fungal pathogens within
this genus, were correctly identified (93/94 isolates).MALDI-TOF
MSwas able to provide species-level identification for 13Aspergil-
lus species isolates which were identified only to the genus level
using morphological characterization in the clinical laboratory
(Table 2). Four isolates required additional analyses with the
SARAMIS software. Only 17/26 (65%) Fusarium species isolates
were identified. For theMucorales, only one out of the threeMucor
species isolates tested was identified and required the additional
SARAMIS analysis. Two-thirds (6/9) of the Rhizopus species iso-
lates were correctly identified using the Knowledge Base version
3.0 database. The database also performed well for the correct
identification of the dimorphic fungi isolates, with 100% of the
Blastomyces dermatitidis (n 4) andHistoplasma capsulatum (n
2) isolates identified. Of the dermatophytes tested, 100% of the
Trichophyton sp. (n  12) and Microsporum sp. (n  2) isolates
were correctly identified.
Misidentifications by VitekMS. There were nomisidentifica-
tions at genus level by the Vitek MS. At the species level, three
isolates were misidentified. Two isolates of Aspergillus amoenus
were identified as Aspergillus versicolor, and one isolate of Asper-
gillus calidoustus was identified as Aspergillus ustus.
Unidentified by Vitek MS. A total of 103 isolates were not
identified by Vitek MS using the Knowledge Base version 3.0 da-
tabase (Table 1). When these isolates were further analyzed using
the modified SARAMIS database, the number of unidentified iso-
lates was reduced to 71. These isolates were sequenced, and of the
71 unidentified isolates, only two isolates, A. fumigatus and Rhi-
zopus microsporus, were included in the database.
Phenotypic identification errors. For isolates that were iden-
tified by phenotype and by Vitek MS, 10 discrepancies were ob-
served (Table 3). This included isolates that were phenotypically
identified as A. fumigatus, Paecilomyces spp., Menispora spp., and
Chrysosporium spp. Sequencing results demonstrated that the Vi-
tek MS system correctly identified all 10 isolates.
DISCUSSION
To our knowledge, this study represents the most comprehensive
evaluation of the Vitek MS and Knowledge Base version 3.0 library
for the identification of filamentous fungi. Themajority of published
studies examining large study sets of filamentous fungi utilize the
Bruker Biotyper MALDI-TOFMS and the associated library and/or
laboratory-developed libraries (10, 11, 15–18). Prior studies have
evaluated the accuracy of MALDI-TOF MS for the identification of
only a few genera or groups of organisms, such asAspergillus spp. or
the dermatophytes (12, 13, 19–26). In our study, which examined
319 isolates from 43 different genera, the Vitek MS version 3.0
library was able to correctly identify 66.8% of isolates and 76.8%
of the isolates after additional SARAMIS analysis.
Seventy-one isolates (22.3%) were not identified using the Vi-
tek MS or the SARAMIS database although only two of the un-
identified isolates were included in the database and could have
potentially been identified. These results are similar to those of
other studies with augmented databases, and our study challenges
the system with a larger number of genera in addition to an up-
dated database and analysis software. Of note, in this investiga-
tion, there were no misidentifications at the genus level, and only
three isolates were incorrectly identified at the species level. Two
isolates, which were determined to be A. versicolor using sequenc-
ing, were identified as the closely related species A. amoenus by
MALDI-TOF analyses. A. amoenus and A. versicolor are both
members of the section Versicolores, and A. versicolor has been
shown to cause onychomycosis and, rarely, pneumonia (27–29).
A third isolate,A. calidoustus, was incorrectly identified asA. ustus
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by MALDI-TOF MS. These two species are closely related, and
previous studies have shown thatmost, if not all, clinical isolates of
A. calidoustuswere previouslymisidentified asA. ustus. The ability
to correctly identify A. calidoustus in the clinical lab is important
due to its resistance to multiple antifungals, including azoles (30,
31). However, the misidentifications encountered in this investi-
gation are unlikely to be clinically significant as a result of the
similarity of these species.
TABLE 1 Performance of the Vitek MS version 3.0 library for the identification of filamentous fungi
Organism




Identified by Knowledge Base
version 3.0 plus modified
SARAMIS database Unidentified Misidentified
Acrodontium salmoneum 1 0 (0.0) 0 (0.0) 1 0
Alternaria spp. 11 10 (90.9) 11 (100) 0 0
Aspergillus spp. 144 125 (86.8) 133 (93.6) 8 3
A. amoenus 2 0 (0.0) 0 (0.0) 0 2
A. calidoustus 1 0 (0.0) 0 (0.0) 0 1
A. carneus 1 0 (0.0) 0 (0.0) 1 0
A. chevalieri 1 0 (0.0) 0 (0.0) 1 0
A. clavatus 2 0 (0.0) 1 (50.0) 1 0
A. flavus 31 28 (90.3) 31 (100.0) 0 0
A. fumigatus 63 61 (96.8) 62 (98.9) 1 0
A. lentulus 2 2 (100.0) 2 (100.0) 0 0
A. nidulans 1 1 (100.0) 1 (100.0) 0 0
A. niger 22 19 (86.3) 22 (100) 0 0
A. sydowii 5 5 (100.0) 5 (100.0) 0 0
A. tennesseensis 1 0 (0.0) 0 (0.0) 1 0
A. terreus 8 8 (100.0) 8 (100.0) 0 0
A. unguis 1 1 (100.0) 1 (100.0) 0 0
A. westerdijkiae 3 0 (0.0) 0 (0.0) 3 0
Beauveria spp. 1 0 (0.0) 0 (0.0) 1 0
Bipolaris spp. 2 2 (100.0) 2 (100.0) 0 0
Blastomyces dermatitidis 4 4 (100.0) 4 (100.0) 0 0
Chaetomium spp. 1 0 (0.0) 0 (0.0) 1 0
Chrysosporium spp. 2 0 (0.0) 1 (50.0) 1 0
Cladosporium spp. 12 2 (16.7) 10 (83.3) 2 0
Coniochaeta velutina 1 0 (0.0) 0 (0.0) 1 0
Coprinellus radians 1 0 (0.0) 0 (0.0) 1 0
Coprinopsis cinerea (Hormographiella) 1 0 (0.0) 0 (0.0) 1 0
Curvularia spp. 5 0 (0.0) 3 (60.0) 2 0
Engyodontium album 1 0 (0.0) 0 (0.0) 1 0
Eutypella scoparia 3 3 (100.0) 3 (100.0) 0 0
Exophiala spp. 2 0 (0.0) 0 (0.0) 2 0
Fusarium spp. 26 17 (65.4) 17 (65.4) 9 0
Ganoderma resinaceum 1 0 (0.0) 0 (0.0) 1 0
Histoplasma capsulatum 2 2 (100.0) 2 (100.0) 0 0
Irpex lacteus 1 0 (0.0) 0 (0.0) 1 0
Libertella spp. 4 0 (0.0) 2 (50.0) 2 0
Malbranchea filamentosa 1 0 (0.0) 0 (0.0) 1 0
Microsporum spp. 2 2 (100.0) 2 (100.0) 0 0
Mucor spp. 3 0 (0.0) 1 (33.3) 2 0
Myrmecridium schulzeri 2 0 (0.0) 0 (0.0) 2 0
Neurospora sitophila 1 0 (0.0) 0 (0.0) 1 0
Nodulisporium spp. 1 0 (0.0) 0 (0.0) 1 0
Oxyporus corticola 1 0 (0.0) 0 (0.0) 1 0
Paecilomyces spp. 4 4 (100.0) 4 (100.0) 0 0
Paraconiothyrium brasiliense 1 0 (0.0) 0 (0.0) 1 0
Penicillium spp. 20 12 (60.0) 12 (60.0) 8 0
Phialemonium obovatum 1 0 (0.0) 0 (0.0) 1 0
Phialophora americana 1 0 (0.0) 0 (0.0) 1 0
Pithomyces chartarum 3 0 (0.0) 0 (0.0) 3 0
Pseudallescheria boydii 10 9 (90.0) 10 (100.0) 0 0
Rasamsonia argillacea complex 4 3 (75.0) 4 (100.0) 0 0
Rhizopus spp. 9 6 (66.7) 6 (66.7) 3 0
Scopulariopsis spp. 6 0 (0.0) 4 (66.7) 2 0
Talaromyces spp. 2 0 (0.0) 0 (0.0) 2 0
Trametes spp. 5 0 (0.0) 2 (40.0) 3 0
Trichoderma spp. 3 0 (0.0) 0 (0.0) 3 0
Trichophyton spp. 12 12 (100.0) 12 (100.0) 0 0
T. interdigitale 5 5 (100.0) 5 (100.0) 0 0
T. rubrum 2 2 (100.0) 2 (100.0) 0 0
T. tonsurans 5 5 (100.0) 5 (100.0) 0 0
Xylomelasma sordida 1 0 (0.0) 0 (0.0) 1 0
Total 319 213 (66.8) 245 (76.8) 71 (22.3) 3 (0.9)
McMullen et al.
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Identification usingMALDI-TOFMSmay overcome the diffi-
culties with traditional identification methods, especially with
sterilemolds and species that aremorphologically similar butmay
differ genetically. UsingMALDI-TOFMS,wewere able to identify
13 different Aspergillus spp. that were identified only to the genus
level using routine phenotypic identification in the clinical labo-
ratory. Additionally, our study demonstrated that there were 10
isolates incorrectly identified using traditional phenotypic meth-
ods. This represents just over 3% of all isolates examined in this
study. Two isolates identified asA. fumigatuswere confirmed to be
Aspergillus lentulus by both MALDI-TOF MS analyses and se-
quencing. A. lentulus was previously considered to be a variant of
A. fumigatus, but additional studies suggest that this is a unique
species (26, 32). A. lentulus has been shown to cause invasive
aspergillosis and has increased azole, amphotericin B, and caspo-
fungin MICs, and this differentiation is clinically important (33–
35). Another study examining the ability of theVitekMS system to
differentiate species of Aspergillus showed that the research-use-
only (RUO) system is able to accurately identify the closely related
species of A. fumigatus and A. lentulus (26).
Other phenotypic misidentifications include five isolates orig-
inally identified as Paecilomyces spp. but identified as Aspergillus
sydowii (one isolate) andRasamsonia argillacea complex (four iso-
lates) byMALDI-TOFMS.Members of the R. argillacea complex,
previously known as Geosmithia spp., are commonly misidenti-
fied as Paecilomyces or Penicillium spp. and are a known, yet rare,
cause of human infection in immunocompromised hosts. R. ar-
gillacea has been identified as a colonizing organism in cystic fi-
brosis patients and as a cause of pulmonary infections. It is resis-
tant to voriconazole, with variable resistance to itraconazole and
amphotericin B (36). Two isolates identified as Menispora spp.
were determined to beEutypella scoparia and one isolate identified
phenotypically as Chrysosporium spp. was identified as Pseudall-
escheria boydii by bothMALDI-TOFMS and sequencing. All four
of these organisms are environmentalmolds and are typically con-
sidered contaminants except for P. boydii, which has been impli-
cated in a variety of illnesses in immunocompromised patients
and in near-drowning victims (37). Accurate identification of this
organism is important due to its decreased susceptibility to many
antifungals, including some azoles, amphotericin B, andmicafun-
gin (38).
MALDI-TOF MS for the identification of molds presents
unique challenges not encountered with other organism types,
such as bacteria and yeasts. As a result of the unique properties of
the filamentous fungi, such as robust cell walls and lower growth
rates, there have beenmany barriers to the development of robust
methods for MALDI-TOF MS identification. To date, a major
limitation of MALDI-TOF MS for mold identification has been
the breadth of commercially available databases. Despite this, a
meta-analysis examining the use ofMALDI-TOFMS for the iden-
tification of yeasts and filamentous fungi showed that while the
analytical performance characteristics are not as desirable as for
the yeasts, the method is able to provide accurate and rapid mold
identification (17). Of note, investigations using expanded labo-
ratory-developed databases have returned a much higher rate of
mold identification (11, 15). Studies examiningMALDI-TOFMS
for the identification of filamentous fungi have used different
MALDI-TOF MS systems, databases (both manufacturer devel-
oped and laboratory developed), and extraction protocols. This
makes it difficult to directly compare the results from different
studies. That said, our study demonstrated a challenge with Fus-
arium sp. identification, even with the additional SARAMIS anal-
yses. Fusarium spp. are important pathogens, especially in immu-
nocompromised hosts, and accurate and rapid diagnosis is
important. This challenge has not been reported in prior publica-
tions although earlier studies have evaluated different systems
and/or hardware (10, 11, 15, 39).
For the Mucorales, another group of clinically important
pathogens, our study identified only 70% of the isolates; this is
consistentwith previous literature, where the rates of correct iden-
tifications for Mucor spp. and Rhizopus spp. range from 66.7% to
100% (10, 11, 15, 39). Previous studies have shown that MALDI-
TOF MS is a rapid and accurate method for the identification of
dermatophytes. There have been many studies examining this
group of molds, with identification rates of90% for these stud-
ies (12, 13, 20–22). Our study correctly identified 100% (14/14) of
the dermatophytes tested. Finally, there have been relatively few
studies examining dimorphic fungi. For our study, we correctly
identified the two H. capsulatum and four B. dermatitidis isolates
tested.
The strength of this study is the evaluation of a large number of
unique isolates using an updated Vitek MS database. However,
this study is not without its limitations, including the facts that the
isolates evaluated are from a single medical center and that some
important species were underrepresented due to lack of available
isolates, especially the thermally dimorphic fungi. In addition, 32
of the isolates were identified using the SARAMIS database; the
ability of a laboratory to fully utilize an augmented database with
the SARAMIS database and superspectra will vary, depending on
the access of the laboratory to a bank of well-curated fungal iso-
lates for comparison.
In summary, the Vitek MS and Knowledge Base version 3.0
library are able to accurately identify filamentous fungi isolated
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from clinical specimens. While nearly one-fourth of the isolates
tested were not found in the database, the addition of the SARA-
MIS software allows the user to easily analyze and add new spectra
to the database. This feature will be a tremendous benefit for lab-
oratories with large collections of clinical isolates. Additional
studies examining the effect of expedited mold identification on
patient outcomes are needed.
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